Amrutanjan Health Care share news, announcements and annual reports
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹493.20.
30 Oct: open ₹488.30, high ₹509.00, low ₹488.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,436 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.60
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 22.14
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 29,73759.9% delivered
Amrutanjan Health Care board meetings
102 filed, newest first. Page 2 of 3.
Feb 2018
Jan 2018
Nov 2017
Aug 2017
May 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
6 May · Board meeting
Apr 2016
Mar 2016
Feb 2016
Oct 2015
Aug 2015
Jul 2015
May 2015
Jan 2015
27 Jan · Board meeting
Inter-alia to consider the following 1. Un-audited financial results for the quarter / nine months ended December 31, 2014. 2. Interim Dividend.
Oct 2014
14 Oct · Board meeting
To consider inter-alia the un-audited financial results for the quarter / half yeard ended 30th September 2014, along with the statement of assets and liabilities for the quarter / half year ended 30th September 2014 (Source MSE)
Aug 2014
1 Aug · Board meeting
To consider inter-alia the un-audited financial results for the quarter ended 30th June 2014. (Source MSE)
May 2014
21 May · Board meeting
Inter alia to consider the Audited Financial Results for the Quarter / Year ended on 31st March 2014 along with Statement of Assets and Liabilities for the year ended on 31st March 2014 and to consider recommendation of Final Dividend for the Financial Year ended on 31st March 2014. (Source MSE)
Jan 2014
29 Jan · Board meeting
Inter-alia to consider the following:- (1). Un-Audited Financial Results for the quarter / Nine month ended on 31st December 2013. (2) Interim Dividend. (Source MSE)
Nov 2013
5 Nov · Board meeting
To Consider inter-alia the Unaudited Financial Results for the Quarter / Half Year ended on 30th September 2013 along with the statement of Assets and Liabilities for the Quarter / Half Year ended on 30th September 2013. (Source MSE)
Jul 2013
29 Jul · Board meeting
To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended 30th June 2013. (Source MSE)
May 2013
21 May · Board meeting
Inter-alia to consider the Audited Financial Results of the Company for the quarter/year ended 31st March 2013; and to consider recommendation of Final Dividend for the Financial year ended 31st March 2013. (Source MSE)
Feb 2013
1 Feb · Board meeting
Inter-alia to consider the following: (1) Un-audited Financial Results of the Company for the quarter / nine months ended 31st December 2012; and 2. Interim Dividend. (Source MSE)
Oct 2012
31 Oct · Board meeting
Due to unforeseen circumstances the meeting of the Board of Directors of the Company scheduled to be held on 7th November 2012, to consider inter-alia the Un-audited Financial Results of the Company for the quarter / Half year ended 30th September 2012, along with the statement of assets and liabilities for the half year ended 30th September 2012, has now been fixed for 9th November 2012. (Source MSE)26 Oct · Board meeting
To consider inter-alia the Un-audited Financial Results of the company for the half year ended 30th September 2012. (Source MSE)
Jul 2012
27 Jul · Board meeting
To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended 30th June 2012. (Source MSE)
May 2012
22 May · Board meeting
Inter-alia to consider the Audited Financial Results for the quarter/year ended 31st March 2012 along with the statement of assets and liabilities for the year ended 31st March 2012. (Source MSE)
Feb 2012
13 Feb · Board meeting
Board of Directors of the Company at their meeting held on 13th February, 2012 , inter -alia, considered and approved the following items: (1) Declared Interim Dividend of Rs. 5/- per share for the year 2011-2012. ( 50% on face value of Rs. 10/-) on the Equity Shares of the Company; (2) Mr. S. Sambhu Prasad, Managing Director of the Company , has been redesignated as Chairman & Managing Director of the Company with effect from February 13, 2012; and (3) Merger of Wholly Owned Subsidiary M/s. Siva's Soft Drinks Private Limited with the Company. (Source MSE)3 Feb · Board meeting
Inter-alia to consider the following: (1) Un-audited Financial Results for the quarter ended 31st December, 2011 and (2) Declaration of Interim Dividend for the nine months ended 31st December 2011. (Source MSE)
Nov 2011
Oct 2011
28 Oct · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the second quarter ended 30th September 2011 (Source MSE)
Jul 2011
22 Jul · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2011. (Source MSE)
Apr 2011
20 Apr · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the Company for the fourth quarter ended 31st March, 2011. (Source MSE)
Feb 2011
10 Feb · Board meeting
Company has fixed 22nd February 2001 as the Record Date for reckoning the members who will be entitled to receive the Interim Dividend for the year 2010-11. (Source MSE)10 Feb · Board meeting
Board of Directors at its meeting held on 10th February, 2011 have declared an Interim Dividend of Rs. 5/- per share ( 50 per cent ) on the Equity Share Capital of Rs. 3.03 Crores for the financial year 2010-11. The Company has further informed that the Interim Dividend shall be paid on or after 28th February 2011, but within the statutory period of 30 days. (Source MSE)
Jan 2011
31 Jan · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the company for the third quarter ended December 31, 2010. (Source MSE)13 Jan · Board meeting
To consider new business proposals. (Source MSE)
Nov 2010
2 Nov · Board meeting
To consider and take on record, inter-alia, the Unaudited Financial Results of the Company for the second quarter ended 30th September, 2010. (Source MSE)
Jul 2010
29 Jul · Board meeting
To consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2010. (Source MSE)6 Jul · Board meeting
To consider the Audited Financial Results of the Company for the year ended 31st March 2010 and also to recommend final dividend on the equity shares of the Company, for the financial year 2009-10. (Source MSE)